The verdict
Our read at a glance.
Whether secretin is understood as an approved diagnostic agent for pancreatic and gastrin testing, rather than a treatment, and whether the well-tested and negative autism claim is kept clearly in view.
- The signal
- As a diagnostic, secretin reliably stimulates the pancreas and is used to test pancreatic function, to help detect gastrin-producing tumors, and to aid pancreatic imaging and procedures. As a treatment for autism, by contrast, multiple randomized trials and systematic reviews found no benefit.
- The unknown
- Its diagnostic role is well defined; the main open questions are practical, such as how secretin-enhanced MRI imaging is best used, rather than any unproven therapeutic role.
- Our read
- A historic hormone with a clear, narrow modern job: it is an approved diagnostic that stimulates the pancreas for testing and imaging. It is not a treatment, and the once-hyped idea that it could help autism was carefully tested and failed, a clean example of a popular claim that the evidence did not support.
The mechanism
How it works.
Secretin is a hormone made by the lining of the upper small intestine. When acidic food arrives from the stomach, secretin is released and tells the pancreas to pour out a watery, bicarbonate-rich fluid that neutralizes the acid. Doctors use that same action as a test: giving secretin by vein makes the pancreas secrete on cue, so they can measure how well it works, collect fluid to look for a gastrin-producing tumor (which responds to secretin in a tell-tale way), or boost the flow and imaging during pancreatic procedures and scans. It is used to read the body, not to change it.
Safety & regulatory boundary
The consequential part.
Secretin is generally well tolerated as a single diagnostic dose, with occasional flushing or nausea and rare allergic reactions. It is approved only as a diagnostic agent, not a treatment, and it should not be used for autism, where controlled trials showed no benefit. ChiRhoStim (synthetic human secretin) is a prescription diagnostic given by a clinician.
What's next
What we're watching.
Refinements in secretin-enhanced pancreatic imaging and testing; no credible new therapeutic indication is on the horizon.
Context
Why this is discussed.
Secretin is a piece of medical history, the hormone whose discovery in 1902 created the whole idea of hormones. Today it is a diagnostic tool. It also became famous in the late 1990s when a small report suggested it might help autism, which set off enormous demand.
The evidence base
10 cited references.
Regulatory & labels1
ChiRhoClin, Inc. (FDA label) · 2025
Registered trials2
ClinicalTrials.gov · PHASE4 · RECRUITING · 2026-03-11
ClinicalTrials.gov · PHASE4 · ENROLLING_BY_INVITATION · 2023-01-18
Indexed literature (PubMed)7
Chatzipanagiotou O et al. · J Neuroendocrinol · 2023
Varshney S et al. · Int J Pancreatol · 1999
Matos C et al. · Semin Ultrasound CT MR · 1999
Choueiri NE et al. · Curr Gastroenterol Rep · 2010
Vege SS · Gastrointest Endosc · 2021
Stevens T et al. · World J Gastroenterol · 2011
Boeck WG et al. · Curr Gastroenterol Rep · 2001
Keep reading